These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 19926015)

  • 21. Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations.
    Miyata K; Ohno S; Itoh H; Horie M
    Intern Med; 2018 Jul; 57(13):1813-1817. PubMed ID: 29434162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.
    Nyegaard M; Overgaard MT; Søndergaard MT; Vranas M; Behr ER; Hildebrandt LL; Lund J; Hedley PL; Camm AJ; Wettrell G; Fosdal I; Christiansen M; Børglum AD
    Am J Hum Genet; 2012 Oct; 91(4):703-12. PubMed ID: 23040497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss-of-function mutations in cardiac ryanodine receptor channel cause various types of arrhythmias including long QT syndrome.
    Hirose S; Murayama T; Tetsuo N; Hoshiai M; Kise H; Yoshinaga M; Aoki H; Fukuyama M; Wuriyanghai Y; Wada Y; Kato K; Makiyama T; Kimura T; Sakurai T; Horie M; Kurebayashi N; Ohno S
    Europace; 2022 Mar; 24(3):497-510. PubMed ID: 34661651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
    van der Werf C; Nederend I; Hofman N; van Geloven N; Ebink C; Frohn-Mulder IM; Alings AM; Bosker HA; Bracke FA; van den Heuvel F; Waalewijn RA; Bikker H; van Tintelen JP; Bhuiyan ZA; van den Berg MP; Wilde AA
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):748-56. PubMed ID: 22787013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms.
    Laitinen PJ; Swan H; Kontula K
    Eur J Hum Genet; 2003 Nov; 11(11):888-91. PubMed ID: 14571276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
    Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA
    J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
    Roston TM; Guo W; Krahn AD; Wang R; Van Petegem F; Sanatani S; Chen SR; Lehman A
    J Electrocardiol; 2017; 50(2):227-233. PubMed ID: 27646203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
    Nof E; Belhassen B; Arad M; Bhuiyan ZA; Antzelevitch C; Rosso R; Fogelman R; Luria D; El-Ani D; Mannens MM; Viskin S; Eldar M; Wilde AA; Glikson M
    Heart Rhythm; 2011 Oct; 8(10):1546-52. PubMed ID: 21699856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release.
    Manotheepan R; Danielsen TK; Sadredini M; Anderson ME; Carlson CR; Lehnart SE; Sjaastad I; Stokke MK
    Cardiovasc Res; 2016 Aug; 111(3):295-306. PubMed ID: 27161030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks.
    Gomez-Hurtado N; Boczek NJ; Kryshtal DO; Johnson CN; Sun J; Nitu FR; Cornea RL; Chazin WJ; Calvert ML; Tester DJ; Ackerman MJ; Knollmann BC
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1　- Modified Schwartz Score.
    Ozawa J; Ohno S; Fujii Y; Makiyama T; Suzuki H; Saitoh A; Horie M
    Circ J; 2018 Aug; 82(9):2269-2276. PubMed ID: 29925740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young.
    Tester DJ; Ackerman MJ
    J Am Coll Cardiol; 2007 Jan; 49(2):240-6. PubMed ID: 17222736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing.
    Tester DJ; Medeiros-Domingo A; Will ML; Haglund CM; Ackerman MJ
    Mayo Clin Proc; 2012 Jun; 87(6):524-39. PubMed ID: 22677073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden death after inappropriate shocks of implantable cardioverter defibrillator in a catecholaminergic polymorphic ventricular tachycardia case with a novel RyR2 mutation.
    Itoh H; Murayama T; Kurebayashi N; Ohno S; Kobayashi T; Fujii Y; Watanabe M; Ogawa H; Anzai T; Horie M
    J Electrocardiol; 2021; 69():111-118. PubMed ID: 34656916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell-derived cardiomyocytes: Comparison of RyR2-R420Q, F2483I, and Q4201R.
    Zhang XH; Wei H; Xia Y; Morad M
    Heart Rhythm; 2021 Feb; 18(2):250-260. PubMed ID: 32931925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
    Duan H; Lu Y; Yan S; Qiao L; Hua Y; Li Y; Zhou K; Wang C
    Medicine (Baltimore); 2018 Apr; 97(16):e0368. PubMed ID: 29668588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.
    Arakawa J; Hamabe A; Aiba T; Nagai T; Yoshida M; Touya T; Ishigami N; Hisadome H; Katsushika S; Tabata H; Miyamoto Y; Shimizu W
    Heart Vessels; 2015 Nov; 30(6):835-40. PubMed ID: 25092222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
    Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel RyR2 Mutation (G3118R) Is Associated With Autosomal Recessive Ventricular Fibrillation and Sudden Death: Clinical, Functional, and Computational Analysis.
    Shauer A; Shor O; Wei J; Elitzur Y; Kucherenko N; Wang R; Chen SRW; Einav Y; Luria D
    J Am Heart Assoc; 2021 Mar; 10(6):e017128. PubMed ID: 33686871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexplained drownings and the cardiac channelopathies: a molecular autopsy series.
    Tester DJ; Medeiros-Domingo A; Will ML; Ackerman MJ
    Mayo Clin Proc; 2011 Oct; 86(10):941-7. PubMed ID: 21964171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.